Interplay of nuclear receptors (ER, PR, and GR) and their steroid hormones in MCF-7 cells

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Molecular and Cellular Biochemistry

• Publication date

  2016-09-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11010-016-2810-2PMID 27632388
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Apigenin inhibits PMA-induced expression of pro-inflammatory cytokines and AP-1 factors in A549 cells

  2015influential reference
• Antiproliferative effect of dexamethasone in the MCF-7 breast cancer cell line

  2015cited by this paper
• The unique transcriptional response produced by concurrent estrogen and progesterone treatment in breast cancer cells results in upregulation of growth factor pathways and switching from a Luminal A to a Basal-like subtype

  2015cited by this paper
• Sex steroid hormone receptors, their ligands, and nuclear and non-nuclear pathways

  2015cited by this paper
• Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes

  2014cited by this paper
• Interaction of Glucocorticoid Receptor (GR) with Estrogen Receptor (ER) α and Activator Protein 1 (AP1) in Dexamethasone-mediated Interference of ERα Activity*

  2013cited by this paper
• Abstract 3572: Unliganded progesterone receptors augment estrogen-induced growth of breast cancer cells via co-regulation of estrogen receptor target genes.

  2013cited by this paper
• Effect of estrogen and tamoxifen on the expression pattern of AP-1 factors in MCF-7 cells: role of c-Jun, c-Fos, and Fra-1 in cell cycle regulation

  2013influential reference
• Coactivators enable glucocorticoid receptor recruitment to fine-tune estrogen receptor transcriptional responses

  2013cited by this paper
• Glucocorticoids augment survival and proliferation of tumor cells.

  2012cited by this paper
• On hormone action in the mammary gland.

  2012cited by this paper
• Activation of the glucocorticoid receptor is associated with poor prognosis in estrogen receptor-negative breast cancer.

  2011cited by this paper
• Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer.

  2010cited by this paper
• Estrogen Receptor, Progesterone Receptor, and Glucocorticoid Receptor Expression in Normal Breast Tissue, Breast In Situ Carcinoma, and Invasive Breast Cancer

  2010cited by this paper
• Hormone action in the mammary gland.

  2010cited by this paper
• Expression of progesterone receptor A form and its role in the interaction of progesterone with cortisol on cyclooxygenase-2 expression in amnionic fibroblasts.

  2009cited by this paper
• Genomic antagonism between retinoic acid and estrogen signaling in breast cancer.

  2009cited by this paper
• Autocrine regulation of cell proliferation by estrogen receptor-alpha in estrogen receptor-alpha-positive breast cancer cell lines

  2009cited by this paper
• Translational regulation mechanisms of AP-1 proteins.

  2009cited by this paper
• Glucocorticoids antagonize estrogens by glucocorticoid receptor-mediated activation of estrogen sulfotransferase.

  2008cited by this paper
• Uranium induces oxidative stress in lung epithelial cells

  2007cited by this paper
• Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy.

  2005cited by this paper
• Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes.

  2005cited by this paper
• Role of mesenchymal-epithelial interactions in mammary gland development

  2005cited by this paper
• Glucocorticoid and mineralocorticoid cross-talk with progesterone receptor to induce focal adhesion and growth inhibition in breast cancer cells.

  2004cited by this paper
• Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action

  2004cited by this paper
• Non-genomic actions of sex steroid hormones.

  2003cited by this paper
• Cell-specific regulation of apoptosis by glucocorticoids: implication to their anti-inflammatory action.

  2002cited by this paper
• Estradiol inhibits glucocorticoid receptor expression and induces glucocorticoid resistance in MCF-7 human breast cancer cells.

  2001cited by this paper
• Expression and function of estrogen receptor subtypes in granulosa cells: regulation by estradiol and forskolin.

  1999cited by this paper
• Mammary gland development is mediated by both stromal and epithelial progesterone receptors.

  1997cited by this paper
• Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element.

  1997cited by this paper
• Role of oestradiol-17 beta in the regulation of synthesis and secretion of human chorionic gonadotrophin by first trimester human placenta.

  1993cited by this paper
• Interference of pathway specific transcription factors.

  1992cited by this paper
• Progestin regulation of cellular proliferation.

  1990cited by this paper
• Non-classical antiestrogenic actions of dexamethasone in variant MCF-7 human breast cancer cells in culture.

  1989cited by this paper
• Steroidal pure antioestrogens.

  1987cited by this paper
• Breast cancer estrogen and progesterone receptor values: their distribution, degree of concordance, and relation to number of positive axillary nodes.

  1983cited by this paper
• Variant T47D human breast cancer cells with high progesterone-receptor levels despite estrogen and antiestrogen resistance.

  1982cited by this paper
• The effects of glucocorticoids and progesterone on hormone-responsive human breast cancer in long-term tissue culture.

  1976cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• Preparation and safety assessment of BADGE- histidine adduct from epoxy-coated cans.

  2025cites this paper
• Signature Analysis of High-Throughput Transcriptomics Screening Data for Mechanistic Inference and Chemical Grouping.

  2024cites this paper
• Cryptobrachytone C from Cryptocarya pulchrinervia (Kosterm) Leaves on Proliferation, Apoptosis, Migration and Clonogenicity of MCF-7 and T47D Cell Lines

  2023cites this paper
• A molecular toolbox to study progesterone receptor signaling

  2023cites this paper
• A body shape index (ABSI) is associated inversely with post-menopausal progesterone-receptor-negative breast cancer risk in a large European cohort

  2023cites this paper
• Antioxidant, Antimicrobial, Cytotoxicity, and Larvicidal Activities of Selected Synthetic Bis-Chalcones

  2022cites this paper
• Choosing the right partner in hormone-dependent gene regulation: Glucocorticoid and progesterone receptors crosstalk in breast cancer cells

  2022cites this paper
• Synthesis, characterization, in vitro biological evaluation and molecular docking studies of newly synthesized mononuclear lanthanum(III) complexes of N,N'-bis(2-aminoethyl)oxamide and phenanthroline bases

  2022cites this paper
• Design, synthesis and anti-breast cancer activity of novel fluorinated 7-O-modified genistein derivatives.

  2022cites this paper
• Cell signaling and apoptosis in animals

  2021cites this paper
• Predisposition of Women to Cardiovascular Diseases: A Side-Effect of Increased Glucocorticoid Signaling During the COVID-19 Pandemic?

  2021cites this paper
• Corticotropin Releasing Factor Receptors in breast cancer: Expression and activity in hormone-dependent growth in vitro.

  2020cites this paper
• PGRMC1 Inhibits Progesterone-Evoked Proliferation and Ca2+ Entry Via STIM2 in MDA-MB-231 Cells

  2020cites this paper
• Progesterone and estrogen regulate NALCN expression in human myometrial smooth muscle cells.

  2020cites this paper
• Steroid enzyme and receptor expression and regulations in breast tumor samples - a statistical evaluation of public data.

  2020cites this paper
• mPRα mediates P4/Org OD02‐0 to improve the sensitivity of lung adenocarcinoma to EGFR‐TKIs via the EGFR‐SRC‐ERK1/2 pathway

  2019cites this paper
• Glucocorticoid-dependent expression of IAP participates in the protection against TNF-mediated cytotoxicity in MCF7 cells

  2019cites this paper
• Structure-biological function study of 17B-hydroxysteroid dehydrogenase type 1 and reductive steroid enzymes : inhibitor design targeting estrogen-dependent diseases

  2019cites this paper
• The glucocorticoid receptor interferes with progesterone receptor-dependent genomic regulation in breast cancer cells

  2019cites this paper
• Sex-related Differences in Calcific Aortic Valve Stenosis: Pathophysiology, Epidemiology, Etiology, Diagnosis, Presentation, and Outcomes

  2018cites this paper
• The Role of Glucocorticoid Receptor Signaling in Bladder Cancer Progression

  2018cites this paper
• Hetero-Binuclear Complexes of Lanthanum (III) Using Bridging N,N′-Bis(2-Pyridylmethyl)Oxamide and Terminal 1,10-Phenanthroline: Synthesis, Characterization and Biological Evaluation

  2018cites this paper
• Chromatin reprogramming in breast cancer.

  2018cites this paper
• Breast Cancer Awareness and Barriers to Early Presentation in the Gaza-Strip: A Cross-Sectional Study

  2018cites this paper
• Deciphering Steroid Receptor Crosstalk in Hormone-Driven Cancers

  2018cites this paper
• Antitumor Effects of Lidocaine on Human Breast Cancer Cells: An In Vitro and In Vivo Experimental Trial.

  2018cites this paper
• Possible roles for glucocorticoid signalling in breast cancer.

  2017cites this paper
• Breast reconstruction – current practice and future directions

  2017cites this paper
• Midostaurin inhibits hormone-refractory prostate cancer PC-3 cells by modulating nPKCs and AP-1 transcription factors and their target genes involved in cell cycle

  2017cites this paper
• Differential expression of AP-1 transcription factors in human prostate LNCaP and PC-3 cells: role of Fra-1 in transition to CRPC status

  2017cites this paper
• Breast cancer in Saudi Arabia and its possible risk factors

  2017cites this paper
• Liposomal curcumin alters chemosensitivity of breast cancer cells to Adriamycin via regulating microRNA expression.

  2017cites this paper
• Concomitant high expression of ERα36, EGFR and HER2 is associated with aggressive behaviors of papillary thyroid carcinomas

  2017cites this paper